Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bright Minds Biosciences Inc. - common stock (NQ: DRUG )

1.650 +0.130 (+8.55%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 39,505
Open 1.520
Bid (Size) 1.560 (3)
Ask (Size) 1.650 (3)
Prev. Close 1.520
Today's Range 1.490 - 1.700
52wk Range 1.470 - 7.400
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
Depression Relief: Possible Therapy Boost With DMT & SSRIs Small Pharma Clinical Results New findings on safety, tolerability and efficacy from a clinical study assessing the interaction of... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're checking out the biggest pre-market stock movers worth watching on Friday with a dive into all of the latest market stories! 
Via InvestorPlace

Performance

YTD
-57.69%
-57.69%
1 Month
-23.96%
-23.96%
3 Month
-42.11%
-42.11%
6 Month
-26.67%
-26.67%
1 Year
-72.50%
-72.50%

More News

Read More
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More
Via Benzinga
Topics Economy
Exposures Interest Rates
Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More
Via Benzinga
Exposures Product Safety
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
Via Benzinga
Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More
Via Benzinga
Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports
Via Benzinga
Topics Cannabis Economy
Exposures Cannabis Interest Rates
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
Via Benzinga
Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session
Via Benzinga
Biotech Market Update: Global Pharmaceuticals Market Expected to Reach $1.5 Trillion by Year’s End
Via FinancialNewsMedia
Exposures COVID-19
Crude Oil Moves Higher; UPS Cuts FY23 Guidance
Via Benzinga
Dow Drops 343 Points Amid Bank Sector Gloom
Via Talk Markets
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Bright Minds Biosciences Inc. (NASDAQ: DRUG) Leading the Way in Tuesday Trading Based on Percentage Gain
Via Investor Brand Network
Bright Mind Shares Surge 91% After Reporting Positive EEG Clinical Results Of Next-Gen Compound
Via Benzinga
Dow Falls 1%; Eli Lilly Raises Annual Guidance
Via Benzinga
Nasdaq Down Over 100 Points; US Trade Deficit Shrinks In June
Via Benzinga
Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More
Via Benzinga
Small Pharma's Q1 2024: Revamping Strategy And Potential Fast-Tracked Clinical Trial
Via Benzinga
Cybin, Bright Minds And PharmAla: A Short Recap On Progress Within Clinical Trials
Via Benzinga
Psyched: NDAA Amendments Blocked, National Practitioners Network, Marijuana In Jackie Kennedy's Garden And More
Via Benzinga
Bright Minds Goes For 5:1 Shares Consolidation, Hopes To Regain NASDAQ Compliance
Via Benzinga
Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More
Via Benzinga
Stress, Anxiety, PTSD: 2 NASDAQ-Listed Drug Developers Advance Psychedelic-Inspired Meds
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.